Abstract Cannabis products (CPs) and cannabis-based medicines (CBMs) are becoming increasingly available and are commonly used for pain management. The growing societal acceptance of cannabis and liberalization of cannabis laws…
Keyword: Cannabidiol (CBD)
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
Abstract The endocannabinoid system shows promise as a novel target for treating psychiatric conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in several psychiatric conditions, with diverse effects…
Therapeutic potential of CBD in Autism Spectrum Disorder
Please use this link to access this publication. Abstract Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by persistent deficits in social communication and interaction, as well as restricted and…
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
Abstract Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The treatment gap in ASD has led to growing interest in alternative therapies, particularly in phytocannabinoids, which are…
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
Please use this link to access this publication. Abstract Adults with ADHD describe self-medicating with cannabis, with some reporting a preference for cannabis over ADHD medications. A small number of psychiatrists in…
Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers
Please use this link to access this publication. Abstract Background: Over the last years, there is a dramatic increase in the use of medical cannabis products for an expanding range of…
Quantification of Cannabis in Infused Consumer Products and Their Residues on SkinClick to copy article link
Please use this link to access this publication. Abstract Cannabis consumer products are a $4.6 billion industry in the U.S. that is projected to exceed $14 billion by 2025. Despite an…
Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury
Please use this link to access this publication. Abstract Skin inflammatory diseases result from complex events that include dysregulation and abnormal expression of inflammatory mediators or their receptors in skin…
Effect of cannabidiol (CBD), a cannabis plant derivative, against Candida albicans growth and biofilm formation
Please use this link to access this publication. Abstract Fungal resistance to available antifungal molecules has emerged as a significant and continued threat. Several plants, including cannabis, have promising antimicrobial…
Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor
Please use this link to access this publication. Abstract Cannabis sativa has been used for improving sleep for long history. Cannabidiol (CBD) has drown much attention as a non-addictive psychoactive component…